Round 1 Winners!
Proof of Usefulness Report

UbiquiTx Inc.

Analysis completed on 3/21/2026

+55.25
Proof of Usefulness Score
You're In Business

While the underlying concept of UbiquiTx (AI-driven programmable protein modulation) demonstrates significant technical innovation and market relevance, the submission contains severe red flags. The inputs for audience reach ('everyone'), evidence of traction ('most people have used my product'), and revenue ('all time marketcap: 50000') are clearly facetious or spam responses that contradict the reality of an early-stage biotechnology firm. These unverified and exaggerated claims trigger substantial penalties in the evaluation.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+50
Audience Reach Impact+0
Technical Innovation+60
Evidence Of Traction-75
Market Timing Relevance+40
Functional Completeness-10
Subtotal+65
Usefulness Multiplierx0.85
Final Score+55

Project Details

Project URL
Description
UbiquiTx focuses on leveraging machine learning and protein engineering to develop programmable protein-modulating therapies. Our AI/ML peptide guide design platform allows us to modulate almost any target protein, allowing for CRISPR-like programmability of protein modulation. The UbiquiTx platform enables fast access to intractable protein targets that have long evaded the industry and is generalizable and applicable to any of nature’s PTMs for programmable protein modulation.

Algorithm Insights

Market Position
Growing utility with room for optimization
User Engagement
Documented reach suggests active user community
Technical Stack
Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline